SIHUAN PHARMAC.GRP HD-,01 financial statements, including revenue, expenses, profit, and loss
The total revenue of TEL1 for the last semiannual is 123.01 M EUR, and it's 21.96% higher compared to the previous semiannual. The net income of H1 24 is -4.33 M EUR.